Page last updated: 2024-08-23

etoposide and Genetic Diseases

etoposide has been researched along with Genetic Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ambra, R; Antonelli, A; Chessa, L; Elli, R; Marcucci, L; Petrinelli, P1
Aulagner, G; Bertrand, Y; Bleyzac, N; Dai, Q; Galambrun, C; Janoly, A; Jelliffe, RW; Magron, P; Maire, P; Martin, P; Souillet, G1

Other Studies

2 other study(ies) available for etoposide and Genetic Diseases

ArticleYear
Effects of topoisomerase II inhibition in lymphoblasts from patients with progeroid and "chromosome instability" syndromes.
    Cancer genetics and cytogenetics, 1996, Volume: 87, Issue:2

    Topics: Ataxia Telangiectasia; Bleomycin; Bloom Syndrome; Cell Line; Cockayne Syndrome; DNA Damage; Etoposide; Genetic Diseases, Inborn; Humans; Lymphocytes; Topoisomerase II Inhibitors; Werner Syndrome; Xeroderma Pigmentosum

1996
Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens.
    Bone marrow transplantation, 2001, Volume: 28, Issue:8

    Topics: Adolescent; Alkylating Agents; Area Under Curve; Bayes Theorem; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Genetic Diseases, Inborn; Graft Survival; Hematologic Neoplasms; Hepatic Veno-Occlusive Disease; Humans; Incidence; Infant; Life Tables; Male; Melphalan; Prospective Studies; Severe Combined Immunodeficiency; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome

2001